Skip to main content

Table 4 Phenotypic antibiotic susceptibility test of S. aureus isolates

From: Benchmarking of two bioinformatic workflows for the analysis of whole-genome sequenced Staphylococcus aureus collected from patients with suspected sepsis

Antibiotic a (n) b

Susceptible (n [%])

Resistant (n [%])

Ciprofloxacin (70)

66 [94.3]

4 [5.7]

Clindamycin (212)

209 [98.6]

3 [1.4]

Erythromycin (215)

212 [98.6]

3 [1.4]

Isoxazolyl penicillin (244)

241 [98.8]

3 [1.2]c

Rifampicin (5)

5 [100.0]

0 [0]

Trimethoprim (26)

25 [96.2]

1 [3.8]

Tetracycline (1)

0 [0]

1 [100.0]

Vancomycin (27)

27 [100.0]

0 [0]

Fusidic acid (206)

196 [95.1]

10 [4.9]

Total amount of cases: 1006

981 [97.5]

25 [2.5]

  1. aAntibiotics reported are dependent on the set of antibiotics included for different sampling at the clinical lab (Additional file 1) and also the antibiotics included in the 1928 platform. bNumber of isolates tested with specific antibiotic disc during the EUCAST test. cFollowed by PCR detection of mecA, confirmation of MRSA
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us